Relapsing polychondritis: A two-case report

Thu Giang, Nguyễn Thị Thoa, Phạm Thu Hằng, Đỗ Thị Huyền Trang, Phạm Văn Tú, Phạm Hoài Thu

Main Article Content

Abstract

Relapsing Polychondritis - RP is an autoimmune disease that damages cartilaginous tissues and organs, and leads to complications if not diagnosed and treated. However, this is a rare disease; onset symptoms can be unspecific and make it difficult for an early diagnosis. The objective of the study was to report two relapsing polychondritis cases, describe diagnostic characteristics for early diagnosis and treatment. A descriptive study design was applied in two patients with relapsing polychondritis admitted to Hanoi Medical University Hospital. Both patients had onset symptoms as auricles and nose inflammation and were not diagnosed before admission. Other symptoms included fever, arthritis and patients were admitted to the hospital. They were diagnosed based on McAdam 1976 criteria and had good treatment responses. In conclusion, early diagnosis and treatment in relapsing polychondritis with anti-inflammatory and immunosuppressant medicine is important to prevent complications.

Article Details

References

1. Hazra N, Dregan A, Charlton J, Gulliford MC, D’Cruz DP. Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study. Rheumatology. Published online July 17, 2015:kev240. doi:10.1093/rheumatology/kev240.
2. Ritter S. Relapsing Polychondritis. In: Rheumatology. 2019. Vol 2. 7th ed. Elsevier; :1480.
3. Trentham DE. Relapsing Polychondritis. Ann Intern Med. 1998;129(2):114. doi:10.7326/0003-4819-129-2-199807150-00011.
4. R. Jaksch-Wartenhorst. Polychondropathia. Intern Med. 1923;6:93-100.
5. Estes SA. Relapsing polychondritis. A case report and literature review. Cutis. 1983;32(5):471-474, 476.
6. Pol K, Jarosz M. Relapsing polychondritis: case report and literature review. Pol Arch Intern Med. 2009;119(10):680-683. doi:10.20452/pamw.805.
7. Ernst A, Rafeq S, Boiselle P, et al. Relapsing Polychondritis and Airway Involvement. Chest. 2009;135(4):1024-1030. doi:10.1378/chest.08-1180.
8. Ben Salah R, Cherif Y, Frikha F, et al. A Relapsing Polychondritis and Malignancies: A Case Report and Review of Literature. J Dermatol Res Ther. 2016;2(6). doi:10.23937/2469-5750/1510041.
9. Lê Thượng Vũ. Trường hợp viêm đa sụn tái tiễn đầu tiên ở Việt Nam. Tạp chí Y Học Thành Phố Hồ Chí Minh. 2004;8:140-145.
10. Borgia F, Giuffrida R, Guarneri F, Cannavò S. Relapsing Polychondritis: An Updated Review. Biomedicines. 2018;6(3):84. doi:10.3390/biomedicines6030084.
11. Piette J-C, El-Rassi R, Amoura Z. Antinuclear antibodies in relapsing polychondritis. Ann Rheum Dis. 1999; 58(10):656-657. doi:10.1136/ard.58.10.656.
12. Wendling D, Godfrin-Valnet M, Prati C. Treatment of Relapsing Polychondritis with Tocilizumab. J Rheumatol. 2013;40(7):1232.1-1232. doi:10.3899/jrheum.130371.
13. Cazabon S, Over K, Butcher J. The successful use of infliximab in resistant relapsing polychondritis and associated scleritis. Eye. 2005;19(2):222-224. doi:10.1038/sj.eye.6701457.
14. Emmungil H, Aydin SZ. Relapsing polychondritis. Eur J Rheumatol. 2015;2(4):155-159. doi:10.5152/eurjrheum.2015.0036.
15. Mathew SD, Battafarano DF, Morris MJ. Relapsing polychondritis in the Department of Defense population and review of the literature. Semin Arthritis Rheum. 2012;42(1):70-83. doi:10.1016/j.semarthrit.2011.12.007